Sex: M
Vaccine: COVID19
Symptoms: Glycosylated haemoglobin, Glycosylated haemoglobin increased, Illness, Pancreatic disorder, Pyrexia
Clinical narrative: This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. A male patient received bnt162b2 (BNT162B2), administration date 21Sep2021 (Lot number: 3013084) as dose 3 (booster), single for Covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 2), for COVID-19 immunization, reaction(s): "uncomfortable", "threw him off for like a half day", "he got sick", "fever of 101 F."; Covid-19 vaccine (Dose 1, Manufacturer unknown), for COVID-19 immunization. The following information was reported: PANCREATIC DISORDER (hospitalization), outcome "recovered", described as "Pancreas "shut down"; BLOOD GLUCOSE INCREASED (medically significant), outcome "unknown", described as "Covid Booster Shot, third shot: blood sugar was 390/increase in blood sugar levels"; GLYCOSYLATED HAEMOGLOBIN INCREASED (non-serious), outcome "unknown", described as "Covid Booster Shot, third shot: A1C was 8.8/A1C was at 6"; ILLNESS (non-serious), outcome "unknown", described as "sick"; PYREXIA (non-serious), outcome "unknown", described as "fever of 101 F."; DISCOMFORT (non-serious), outcome "unknown", described as "discomfort". The events "pancreas "shut down", "Covid booster shot, third shot: blood sugar was 390/increase in blood sugar levels", "Covid booster shot, third shot: a1c was 8.8/a1c was at 6", "sick", "fever of 101" and "discomfort" were evaluated at the physician office visit. The patient underwent the following laboratory tests and procedures: blood glucose: 140; 390, notes: Two and a half weeks later; around 100-120 on average; increase; blood test: pancreas seems to be working correctly again, notes: but it had shut down; body temperature: 101; glycosylated haemoglobin: 6; 8.8, notes: Two and a half weeks later; 5.7; around 6. Therapeutic measures were taken as a result of pancreatic disorder, blood glucose increased, glycosylated haemoglobin increased. He went to his cardiologist and had bloodwork done which showed his blood sugar was 140 and his A1C was at 6. Two and a half weeks later he went to his primary care physician and had a blood sugar was 140 and his A1C was at 6 there, which showed his blood sugar was 390 and A1C was 8.8. His pancreas basically shut down so he went to the hospital overnight. The patient was put on 30 units of insulin plus metformin. He stayed on that for several months, really watched his diet and got his A1C back down to 5.7. So then was put on JANUVIA and metformin. He just stopped taking JANUVIA. His blood sugar was still around 100-120 on average and his A1C was around 6. He was scheduled for another blood test. His pancreas seemed to be working correctly again but it had shut down. His concern was regarding getting another COVID Booster Shot. He has an endocrinologist who said in the community there was some talk of blood sugar raising and these events. The patient's doctor was more perplexed at how the blood sugar and A1C could spike like that in 2.5 week period. No follow-up attempts are possible. No further information is expected.